If you’d invested in: Indivior and Next

Drugmaker Indivior is on the up, while retailer Next, once a favourite with investors, has lost its way.

If only


Indivior (LSE: INDV) is a pharmaceutical company that specialises in producing Suboxone, a prescription drug for the treatment of patients who are dependent on opioids. The firm operates in 40 countries worldwide. It was set up in 1994 as the pharmaceuticals division of consumer goods giant Reckitt Benckiser, but was spun off in December 2014 and listed as Indivior on the London Stock Exchange.In its first year as a public company, it made an operating profit of $346m on revenue of $1bn. Over the last year, the shares have risen by more than 130%.

Be glad you didn't


Fashion retailer Next (LSE: NXT) was once a favourite with investors. Between 2008 and late 2015, its shares rose by almost ten times. But since then, the company has lost its way as retail trends change. Last year proved difficult as customers deserted the chain, leading to multiple profit warnings. There's no relief in sight: last month, the firm warned that 2017 will be even tougher. The share price has slumped by over 40% in the past year.



Share tips

Share tips of the week

MoneyWeek’s comprehensive guide to the best of this week’s share tips from the rest of the UK's financial pages.
17 Jan 2020
Investment strategy

How the fear of death affects our investment processes

Many of our investment decisions are driven by one simple fact: the knowledge that, one day, we will be dead. Here, in an extract from his new book, J…
2 Jan 2020
Share tips

Share tips: eight stocks that should deliver robust returns

Ryan Ermey of US publication Kiplinger’s Personal Finance chooses his favourite stocks for the next decade, which should be able to grow for years.
28 Dec 2019

The good investments of the 2010s – and the bad

John Stepek takes a look back on which investments did well and which did badly in the decade that’s about to come to an end.
26 Dec 2019

Most Popular


These seven charts show exactly why you must own gold today

Covid-19 is accelerating many trends that were already in existence. The rising gold price is one such trend. These seven charts, says Dominic Frisby,…
3 Jun 2020
EU Economy

Why a stronger euro is good news for investors

The fragile state of the eurozone has for a long time brought the threat of deflation. But the ECB’s latest moves have dampened those fears. John Step…
5 Jun 2020
Emerging markets

Putin’s grip on power is slipping

The Russian president had been looking forward to a spring of triumphs, including a new constitution that strengthens his hand. Now he faces multiple …
6 Jun 2020